Table 4.
General clinical data for the patient populations.
| Parameter | Population | Total populations | No complications | Nephro-pathy | Retino-pathy | Cardiovascular |
| Number of patients (% of total population) | Ash | 762 | 269 (35.3) | 308 (40.4) | 118 (15.5) | 261 (34.3) |
| Seph | 191 | 65 (34) | 69 (36.1) | 37 (19.4) | 60 (31.4) | |
| NAF | 226 | 74 (32.7) | 88 (38.9) | 61 (27) | 52 (23) | |
| M/F (%) | Ash | 50/50 | 38/62 | 54/46 | 57/43 | 62/38 |
| Seph | 51/49 | 48/52 | 55/45 | 54/46 | 62/38 | |
| NAF | 48/52 | 42/58 | 53/47 | 48/52 | 63.5/36.5 | |
| Age (mean ± SD) | Ash | 65.7 ± 9.9 | 64.3 ± 10 | 65.9 ± 9.7 | 64.6 ± 9.2 | 68.0 ± 9.2 |
| Seph | 65 ± 9 | 64.3 ± 8.4 | 65.1 ± 8.8 | 64.6 ± 8.2 | 66.8 ± 8.6 | |
| NAF | 61.9 ± 9.4 | 60.7 ± 10.0 | 62.4 ± 8.9 | 61.6 ± 10.3 | 63.1 ± 8.8 | |
| Years of diabetes (mean ± SD) | Ash | 18.9 ± 8.3 | 16.8 ± 7.3 | 19.2 ± 8.4 | 22.9 ± 8.5 | 20.9 ± 9.0 |
| Seph | 19.4 ± 8.4 | 21.4 ± 8.8 | 20.5 ± 9.2 | 24 ± 9.1 | 21.2 ± 8.2 | |
| NAF | 19 ± 7.3 | 16.8 ± 6.4 | 19.4 ± 7.3 | 22.4 ± 7.9 | 19.7 ± 7.9 | |
| BMI1 (kg/m2, mean ± SD) | Ash | 29.9 ± 5.2 | 28.8 ± 4.6 | 30.6 ± 5.5 | 30.8 ± 6.0 | 29.7 ± 5.0 |
| Seph | 30.3 ± 4.9 | 30.7 ± 5.4 | 30.4 ± 5.3 | 30.5 ± 5.7 | 30.5 ± 5 | |
| NAF | 29.6 ± 5.1 | 28.8 ± 4.8 | 30.6 ± 5.1 | 30.3 ± 5.3 | 30.9 ± 4.5 | |
| HbA1c (mean ± SD) | Ash | 7.9 ± 1.5 | 7.8 ± 1.4 | 8.0 ± 1.5 | 8.2 ± 1.6 | 7.9 ± 1.4 |
| Seph | 8.2 ± 1.6 | 8.2 ± 1.7 | 8.2 ± 1.4 | 8.2 ± 1.6 | 8.3 ± 1.6 | |
| NAF | 8.7 ± 1.9 | 8.7 ± 2.0 | 8.8 ± 2.0 | 8.6 ± 1.6 | 8.7 ± 1.9 | |
| HTN2 (%) | Ash | 72.9 | 61.3 | 81.8 | 79.7 | 77.4 |
| Seph | 70.2 | 73.8 | 81.2 | 86.5 | 81.7 | |
| NAF | 61.5 | 54.1 | 69.3 | 72.1 | 65.4 | |
| LDL-c (mg/dl, mean ± SD) | Ash | 104.0 ± 31.0 | 108.7 ± 31.1 | 102.3 ± 29.7 | 103.3 ± 27.9 | 98.2 ± 30.5 |
| Seph | 109.3 ± 36.7 | 106 ± 36 | 107.1 ± 39 | 110.9 ± 38 | 96.1 ± 29.4 | |
| NAF | 104.7 ± 29.8 | 104.9 ± 28.3 | 106.3 ± 27.8 | 105.6 ± 36.6 | 102.5 ± 31 |
1 BMI = Body mass index 2 HTN – Hypertension